The Ian G. Jacobs Award for International Group Collaboration to Advance Resuscitation Science was presented to the Core Outcome Set for Cardiac Arrest (COSCA), 3 a partnership of patients, families, clinicians, researchers, and the International Liaison Committee on Resuscitation (ILCOR) that acknowledges the values and preferences of all stakeholders, particularly patients and their families. This year's Best Oral Abstract awards were presented to Linn Andelius, Emmanuel O. Akintoye, Ernesto Lopez, and Takayuki Ogura. Andelius's study focused on of the effect of smartphone applications on bystander defibrillation participation. Lopez's research evaluated antithrombin III's contribution to the protective and reparative effects of fresh frozen plasma following hemorrhagic shock. Akintoye's research highlighted the importance of modifiable social determinants such as insurance type and hospital percutaneous coronary intervention capability of health in patient outcomes as significant predictors of survival to hospital discharge after cardiopulmonary resuscitation (CPR) for in-hospital cardiac arrest (IHCA). Ogura studied the use of the prehospital traumatic bleeding severity score as a predictor of massive transfusion utilization (Table S2) . Table S3 provides names, titles, and research fields of winning abstracts.
Women in Resuscitation Science Networking Meeting
This year's Women in Resuscitation Science focused on the gender pay gap and teaching salary negotiation for women in the workplace, sponsored by the American Association of University Women. During this workshop, participants learned the fundamentals of salary negotiation through facilitated discussion and role playing.
Japanese Circulation Society and AHA Session
ReSS continued the long tradition of a joint session between the Japanese Circulation Society and the AHA. Dr Yoshio Tahara of the National Cerebral and Cardiovascular Center Hospital (Osaka, Japan) illustrated how extracorporeal membrane oxygenation, coronary angiography, and temperature management have been aggressively implemented in Japan over the past decade. Dr Jon Rittenberger of the University of Pittsburgh (Pittsburgh, PA) shared data from the Pittsburgh Post-Cardiac Arrest Service demonstrating how the initial neurologic examination is used for prognostication and for determining the patients most likely to benefit from early coronary angiography and electroencephalography monitoring. Dr Eji Hirakawa of Nagasaki University (Nagasaki, Japan) demonstrated the difference between surface and brain temperature in the postarrest patient and discussed optimal temperature management for this population.
Population Health Initiatives Dispatch-Assisted CPR: From Saving Lives to Implementation
The plenary session, "Dispatch-Assisted CPR: From Saving Lives to Implementation," was a multiperspective panel that described the experience of an emergent cardiac arrest from the point of view of all stakeholders, including a survivor, a family member, good Samaritans/laypeople, a rehabilitation specialist, and a dispatcher. Each panelist described the same event from his or her unique perspective, painting a multifaceted picture of the faceless heroes on the other end of the phone who make the difference between life and death. The discussion emphasized the crucial parts played by all parties in successful outcomes for cardiac arrest.
Saving Lives Through Public Health Initiatives
Dr Bernd B€ ottiger from Cologne, Germany, gave an inspiring talk on the "Kids Save Lives" campaign (https://www.youtube.c om/watch?v=0Yf4umHnD3c "Kids Save Lives", n.d. 
Resuscitation Health Services Research, Adult and Pediatric Epidemiology
Texas researchers presented data on sex differences in outcomes among those with out-of-hospital cardiac arrest, finding that women, although having higher rates of return of spontaneous circulation (ROSC), have lower survival when adjusting for confounders. The session concluded with a discussion about the cost-effectiveness of public access automated external defibrillators (AEDs). Researchers from Denmark investigated the return on investment of public AEDs. Their findings suggest that it costs about $54 000 for public AEDs to provide 1 quality-adjusted life-year, which is well within World Health Organization and AHA high/ intermediate values for interventions.
Dr Victoria L. Vetter from the Children's Hospital of Philadelphia discussed the impact of legislation in 38 states requiring CPR training as a graduation requirement. Although "CPR in Schools" is associated with a 17% to 25% increase in bystander CPR rates across all ages and in every state where it was enacted, significant disparities among gender and race still exist.
Dr Mathias J. Holmberg from Beth Israel Deaconess Medical Center (Boston, MA) presented a new analysis of "Get With The Guidelines-Resuscitation" to measure the incidence of IHCA in US hospitals. Compared with previous estimates, there are >310 000 IHCA victims in the United States annually, suggesting a large and growing burden of disease. Meanwhile, the number of pediatric IHCAs has decreased, estimated at 7100 annually, demonstrating that IHCA is often predictable and thus preventable.
Dr Lars W. Andersen from Aarhus University in Denmark and his team presented a cost-effectiveness analysis of public access defibrillation. He concluded that public access defibrillation costs $54 000 for each quality-adjusted life-year saved. The cost of public access defibrillation per qualityadjusted life-year saved meets the generally accepted threshold of $50 000 per quality-adjusted life-year for costeffectiveness and is comparable to other generally accepted cardiovascular interventions considered efficacious.
Researchers from Michigan, now a statewide partner in CARES (Cardiac Arrest Registry to Enhance Survival), presented data on the estimated patient-standardized clinical outcomes for OHCA across emergency medical services (EMS) agencies in Michigan. Significant variability exists, with the highest performing EMS agencies achieving 40% ROSC and the lower performing agencies achieving 11% ROSC.
Improving CPR Education for Laypeople and Professionals
During the closing session of ReSS, several presentations discussed issues surrounding improving CPR education and decreasing barriers to layperson response. In the United States, state legislation requiring CPR training in schools has resulted in more people trained and an increase in the number of patients discharged after cardiac arrest with favorable functional outcomes. Nevertheless, gender and racial gaps remain regarding lay rescuer response among those studied.
Closed caption television videos were reviewed to observe and describe what real-life cardiac arrest events look like in the out-of-hospital setting. For patients suffering cardiac arrest, there is often a prodrome of unsteady gait, agonal breathing, and abnormal posturing. For lay rescuers responding, responses range from shaking or shouting at the person, holding the head of the person, and attempting to stand them up or lift their legs. In an Arizona community, residents were engaged, trained, and asked to voluntarily take calls to allow researchers to study the response time of lay rescuers versus EMS providers for both chest compressions and AED delivery. In multiple simulated scenarios, lay rescuers demonstrated faster response times compared with EMS. In Australia, cardiac rehabilitation patients were targeted for increased CPR training efforts. Preliminary results suggest that CPR training can be implemented in cardiac rehabilitation programs but that time requirement to do so is still a barrier to implementation.
Last, researchers from the University of Pennsylvania (Philadelphia, PA) presented data on the implications of legislative efforts for CPR education. This presentation utilized national telephone survey data on CPR education to compare states with mandates for implementation of CPR training in school education to those without. The findings suggest that in states with current mandates, the younger population (aged 18-24 years) is significantly more likely to be trained. Table 1 provides a summary of oral presentations on population health initiatives.
Clinical Research
Managing the Airway During Resuscitation Dr Pierre Carli, from the Necker-Enfants Malades Hospital (Paris, France) presented, "EMS Approaches to Airway in the Cardiac Arrest Airway Management (CAAM) Trial." CAAM is a prehospital noninferiority trial of bag-mask ventilation versus endotracheal tube (control group) conducted in Europe, where the standard practice involves airway management performed by physicians. Patients were randomized on scene, and the primary outcome was survival with good functional outcome (cerebral performance category 1-2 at 28 days). Results from the intention-to-treat analysis showed no significant difference in outcome between groups.
Dr. Jerry Nolan from the Royal United Hospital in Bath UK, presented results from the study: Effect of a Strategy of a Supraglottic Airway Device vs Tracheal Intubation During Outof-Hospital Cardiac Arrest on Function Outcome, The AIR-WAYS-2 Randomized Clinical Trial. Clustering occurred at the EMS level, and the primary outcome was good functional outcome at 30 days or hospital discharge, whichever occurred first. Results demonstrated a significant benefit for patients managed with a supraglottic airway regarding initial airway success but also the loss of an established initial airway. In sensitivity analysis, patients with good functional recovery were significantly more likely to have had the supraglottic airway first (odds ratio: 2.06; 95% CI, 1.51-2.81), compared with the tracheal intubation group. Dr Daniel W. Spaite from the University of Arizona (Tucson, AZ) presented, "Airway Management and Ventilation During Traumatic Injury." Dr Spaite highlighted that trials on airway management are likely confounded by differences in ventilation practices, unintentionally because ventilation is not standardized or measured consistently. More attention to ventilation technique is needed for clinical practice, and future airway trials must consider how to control for ventilation variation and impact.
Circulatory Support for Cardiac and Trauma Emergencies
The plenary session, "Circulatory Support for Cardiac and Trauma Emergencies," featured a panel of international experts discussing strategies to treat cardiovascular and traumatic shock. Dr Theresa M. Olasveengen from Oslo, Norway, showed preclinical data demonstrating how these models have been used to determine the optimal timing for 
New Insights Into Postarrest Assessment and Care
The session "New Insights Into Post-Arrest Assessment and Care" was presented on an array of long-term effects of cardiac arrest. Dr Sachin Agarwal of Columbia University (New York, NY) reported on a study of 114 cardiac arrest survivors over 12 months. He noted that survivors have a 36% screened positive rate for posttraumatic stress disorder at hospital discharge and 28% at 1 year after cardiac arrest. These participants tended to be younger and female and to have preexisting psychiatric diagnoses. Participants with posttraumatic stress disorder had consistently higher risk of 12-month risk of major adverse cardiac events and all-cause mortality. 7 Dr Matthias Kohlhauer of Maisons-Alfort, France, presented data from a rabbit model of cardiac arrest instrumented to capture temperature, cerebral blood flow, cerebral vascular resistance, and arterial/venous differences in cerebral glucose, oxygen, and metabolic substrates. He found that ultra-rapid induction of hypothermia with total liquid ventilation reduced cerebral consumption of oxygen and glucose and reversed the lactate/pyruvate ratio compared with control animals. 8 Dr Marco Hefti of the University of Iowa in Iowa City described a piglet model of pediatric cardiac arrest in which animals were randomized to inhaled nitric oxide or control after ROSC. Transcriptional profiling of cerebral tissue revealed differential gene expression related to synaptic transmission.
Dr Min Yang of Anhui Medical University (Hefei, China) noted the prevalence of postmyocardial dysfunction in the post-cardiac arrest syndrome and that exposure to epinephrine during resuscitation seems to exacerbate it. She tested ivabradine, a pharmacologic agent that reduces heart rate by inhibiting specific portions of the intrinsic pacemaker current, as a protective agent in a porcine model of cardiac arrest. Animals receiving ivabradine had lower heart rates, less echocardiographic evidence of myocardial dysfunction, and less histologic evidence of myocardial injury compared with controls.
Dr Ramani Balu of the University of Pennsylvania (Philadelphia, PA) presented human data on dynamic cerebrovascular autoregulation from a single-center cohort of human participants with diffuse hypoxic brain injury. Cerebrovascular pressure reactivity manifested in different phenotypes in participants who regained consciousness or remained in a vegetative state. Furthermore, cerebrovascular pressure reactivity had better discrimination of participants with and without eventual return of consciousness than intracranial pressure or brain tissue oxygenation.
Exploring Devices and Algorithms
A session exploring the use of devices and algorithms in resuscitation drew considerable attention as presenters shared data on the use of extracorporeal membrane oxygenation in patients with prolonged resuscitation, examined the associated outcomes of intravenous versus intraosseous access in OHCA, and introduced a novel AED algorithm that allows for continuous chest compressions while the device measures a rhythm, reducing resuscitation interruptions markedly. Dr Felipe Teran from the University of Pennsylvania (Philadelphia, PA) gave a visually captivating presentation on the use of transesophageal echocardiography intra-arrest in OHCA patients with preliminary data demonstrating safety, feasibility, and clinical impact. A key finding of this preliminary work is that in 41% of cardiac arrest cases, the area of maximal compression was found in the left ventricle; in the other 53%, it was in the aortic root or left ventricular outflow tract. 9 Dr Corina De Graff from Academisch Medisch Centrum Amsterdam presented on her team's work on prospectively evaluating a new algorithm (cprINSIGHT) which can analyze the ECG while rescuers continue CPR. The results show that this novel algorithm could analyze the ECG without the need for a pause in chest compressions 65% to 74% of the time and had 90% to 100% sensitivity and 100% specificity when it made a shock or a no shock decision.
Dr Jason Bartos from the University of Minnesota presented a study examining the effects of resuscitation duration on neurologically intact survival in the Minnesota ROC extracorporeal cardiopulmonary resuscitation protocol. They found that 41% of patients receiving full resuscitative efforts were discharged neurologically intact; however, neurologically intact survival declined with increasing duration of CPR, with 100% survival in patients placed on extracorporeal life support within 30 minutes. Survival declined to 50% within 50 minutes and to 20% within 70 minutes, and the metabolic profile worsened during prolonged CPR.
A popular topic in this year's agenda was the comparison of intraosseous versus intravenous access for the delivery of advanced life support drugs. Dr Purav Mody from the University of Texas Southwestern (Dallas, TX) brought us further discussion of this topic with a presentation of data from the ROC Continuous Chest Compression Trial. 10 Among 19 731 patients with available access information, intraosseous or intravenous access was attempted in 15.5% and 84.5% of patients, respectively, and was successful in 97% and 92% of these patients. Patients with attempted intraosseous access were actually very different: they were younger, were more likely female, received less bystander CPR, had lower proportions of shockable and witnessed arrests, had marginally faster times to access and to epinephrine administration, and less frequently received therapeutic hypothermia and coronary angiography compared with patients with intravenous access. Table 2 provides a summary of oral presentations on clinical research.
Late-Breaking Abstracts in Resuscitation Science
Dr Gavin Perkins of the University of Warwick (Coventry, UK) shared the findings of the PARAMEDIC2 (Prehospital Assessment of the Role of Adrenaline: Measuring the Effectiveness of Drug Administration in Cardiac Arrest) 11 trial during the first late-breaking session. The trial demonstrated higher 30-day survival for the epinephrine group (3.2% epinephrine versus 2.4% for placebo) but not in survival with favorable neurologic outcome on discharge (2.2% in the epinephrine group and 1.9% in the placebo group). Dr Peter J. Kudenchuk of the University of Washington (Seattle, WA) presented a secondary analysis from the ROC. Their goal was to determine whether intraosseous or intravenous administration of medication was associated with outcome. Although the intraosseous group received a higher percentage of CPR during their resuscitation, the survival benefit of administering amiodarone or lidocaine was not found in the intraosseous group. Administering amiodarone or lidocaine did improve survival in the intravenous group. Dr Jasmeet Soar, chair of the advanced life support subcommittee of Southmead Hospital (Bristol, UK), then revealed the new ILCOR recommendations on antiarrhythmic drug use during CPR and after ROSC. 12 Given the results of the above trial, either lidocaine or amiodarone can be used in ventricular fibrillation/ventricular tachycardia cardiac arrest. These 2 presentations illustrated how ILCOR rapidly incorporated new data into its guidelines.
Year In Review: Trauma and Cardiac Arrest
At the cardiac year in review, Dr Clifton Callaway highlighted 2018's major studies on epinephrine, 11,13,14 airway management, 5, 6 and variation in outcome between regionalized EMS and cardiac arrest centers. [15] [16] [17] Unique in the past year were studies on teamwork, resuscitation science education, 18 and resuscitation training. Finally, the Core Outcome Set for Cardiac Arrest Clinical Trials (COSCA) 3 collaboration defined a new benchmark for good clinical practice in cardiac arrest trials, recommending study outcomes to include measurement and reporting of survival (discharge or 30 days), functional outcome (discharge or 30 days), AND health-related quality of life at 90 days. In his review of 2018's trauma research developments, Dr Samuel Tisherman of Baltimore, MD, highlighted the Stop the Bleed campaign and a study demonstrating that teaching laypeople to use tourniquets is feasible and optimal with an inperson course, compared with using flashcards, an audio training kit, or no training at all. This session also highlighted studies in prehospital plasma, suggesting that it may be beneficial with long transports and blunt injury. Finally, researchers are revisiting hypothermia as a treatment for traumatic brain injury. The POLAR-RCT (Prophylactic Hypothermia Trial to Lessen Traumatic Brain Injury-Randomized Clinical Trial) 19 tested early prophylactic hypothermia in patients with severe traumatic brain injury versus controlled normothermia. There was no significant difference in favorable functional outcome or independent living at 6 months after injury in the hypothermia group. Dr Per Nordberg of the Karolinska Institute (Stockholm, Sweden) discussed the long-awaited PRINCESS (Prehospital Resuscitation Intra-Arrest Cooling Effectiveness Survival Study), 20 which used a transnasal cooling device to deliver targeted temperature management to 34°. Patients in the investigational arm arrived at target temperature significantly faster (time to target 101 versus 182 minutes) than controls. However, there was no significant difference in functional outcome at 90 days between groups.
Basic Science Laboratory Studies of CPR and Postarrest Recovery
The session on CPR and postarrest recovery discussed a range of themes from brain function to the effect of elevation on cerebral perfusion pressure. Dr Qinyue Guo of Virginia Commonwealth University (Richmond, VA) presented data on the effects of PEG-20k (polyethylene glycol 20k) administered on initiation of chest compressions in a randomized cardiac arrest model of Sprauge-Dawley rats. Animals receiving PEG-20k had reduced cerebral edema, as measured by wet-to-dry ratio of the brain, and cerebral microcirculation, as measured by sidestream dark-field imaging. 21 Dr Wolfgang Weihs of the Medical University of Vienna (Vienna, Austria) described an observation in his rat model of MN) presented a serendipitous observation from her laboratory studying a porcine model of "heads-up CPR" in cardiac arrest. While testing different degrees of head angle (20°, 30°, and 40°) during CPR, they noticed that animals with a progressive increase in head elevation (ie, moving from 20°to 40°) displayed higher cerebral and coronary perfusion pressures compared with animals with progressive decrease in head elevation (ie, moving from 40°to 20°). The improved hemodynamics were largely driven by an increase in mean aortic pressure and a decrease in intracranial pressure.
22 Table 3 provides a summary of oral presentations on basic science.
Social Media Impact of ReSS 2018
During ReSS 2018 the conference hashtag #ReSS18 was used to disseminate and amplify, in real time via Twitter, the science presented during the conference. Analysis of social media activity including the hashtag #ReSS18 using Symplur healthcare social medial analytics (Symplur), shows that there were >2000 tweets throughout the 3-day conference, engaging 454 users worldwide who generated 7.7 million impressions and shared 68 articles and >1800 visuals. Figure  depicts a chart with the 50 most frequently used terms using the hashtag #ResSS18. 
Conclusion
ReSS 2018 was, once again, an outstanding opportunity for resuscitation science researchers to meet and present the latest in cardiac arrest research, from basic science to clinical trials and public health interventions. 
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